CERO THERAPEUTICS HOLDINGS, INC.

Profile

Company Names

CERO THERAPEUTICS HOLDINGS, INC.

Addresses

201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

650-407-2376

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$16,443,654.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-04-22 
$5,000,000.00 
$8,000,000.00 
$3,000,000.00 
Equity 
2
2024-09-26 
$1,250,000.00 
$1,250,000.00 
$0.00 
Equity 
1
2024-02-14 
$10,193,654.00 
$10,193,654.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN 
 
ATWOOD 
EXECUTIVE OFFICER, DIRECTOR
IMMUNE DESIGN CORP.   |  VERACYTE, INC.   |  MIRINA CORP   |  FIVE PRIME THERAPEUTICS INC   |  GROOVE BIOPHARMA CORP   |  PHASERX, INC.   |  ATRECA, INC.   |  CELL DESIGN LABS, INC.   |  CERO THERAPEUTICS HOLDINGS, INC.
BRIAN 
G. 
ATWOOD 
DIRECTOR
HELICOS BIOSCIENCES CORP   |  PHASERX INC   |  OPGEN INC   |  TRIUS THERAPEUTICS INC   |  VERSANT AFFILIATES FUND I-B LP   |  VERSANT AFFILIATES FUND I-A LP   |  VERSANT SIDE FUND I LP   |  VERSANT SIDE FUND II, LP   |  PHASERX, INC.   |  CLOVIS ONCOLOGY, INC.   |  VERACYTE, INC.   |  CERO THERAPEUTICS HOLDINGS, INC.
MICHAEL 
 
BYRNES 
DIRECTOR
CERO THERAPEUTICS HOLDINGS, INC.   |  FORE US BIO INC.
CHRIS 
 
EHRLICH 
EXECUTIVE OFFICER, DIRECTOR
BIOMIMETIC THERAPEUTICS, INC.   |  QUATRX PHARMACEUTICALS CO   |  INVUITY, INC.   |  SATORI PHARMACEUTICALS INC   |  CARBYLAN BIOSURGERY, INC   |  CERO THERAPEUTICS HOLDINGS, INC.
ANDREW 
ALBERT 
KUCHARCHUK 
EXECUTIVE OFFICER
CERO THERAPEUTICS HOLDINGS, INC.
KATHLEEN 
 
LAPORTE 
DIRECTOR
AFFYMAX INC   |  BOLT BIOTHERAPEUTICS, INC.   |  CERO THERAPEUTICS HOLDINGS, INC.
SHAMI 
 
PATEL 
DIRECTOR
GOLDEN PACIFIC BANCORP INC   |  FINTECH ACQUISITION CORP   |  INSURATE, INC.   |  CERO THERAPEUTICS HOLDINGS, INC.
KRISTEN 
 
PIERCE 
EXECUTIVE OFFICER
CERO THERAPEUTICS HOLDINGS, INC.
ROBYN 
 
RAPAPORT 
DIRECTOR
CERO THERAPEUTICS HOLDINGS, INC.
LINDSEY 
 
ROLFE 
DIRECTOR
CERO THERAPEUTICS HOLDINGS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-05-06
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2025-04-22 
2024-10-04
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2024-09-26 
2024-02-23
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2024-02-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
J.V.B. FINANCIAL GROUP, LLC
149758